{
 "PrintNo":"A10679","Session":2023,"Chamber":"ASSEMBLY","BillType":"Assembly","Published":"2024-08-28T13:13:43.282769Z",
 "Status":"IN_ASSEMBLY_COMM","Committee":"Insurance",
 "Milestones":[{"Type":"IN_ASSEMBLY_COMM","Date":"2024-08-28","Committee":"Insurance"}],
 "Actions":[{"Text":"REFERRED TO INSURANCE","Date":"2024-08-28","Chamber":"ASSEMBLY"}],
 "Sponsors":[{"ID":1105,"Name":"Pamela J. Hunter","Short":"HUNTER"},{"ID":540,"Name":"Amy Paulin","Short":"PAULIN"}],
 "Title":"Establishes a mandated window of five business days for both Medicaid and private insurers to respond to pre-authorization claims for testing and/or treatments made by physicians on behalf of oncology patients",
 "Summary":"Establishes a mandated window of five business days for both Medicaid and private insurers to respond to pre-authorization claims for testing and/or treatments made by physicians on behalf of oncology patients.",
 "LawSection":"Insurance Law","LawCode":"Amd ยง3238, Ins L",
 "ActClause":"AN ACT to amend the insurance law, in relation to establishing a mandated window of five business days for both Medicaid and private insurers to respond to pre-authorization claims for testing and/or treatments made by physicians on behalf of oncology patients",
 "SameAsPrintNo":"S9858-2023"
}